Post-treatment neurocognitive performance
Related entities
Findings (27)
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49
None
declineSurvivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai
Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49